Fundraising FoxYosemite — 2025 Investments
9 investments dated 2025 · listed companies and verified rows first · show all
Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds.
BiotechDeep TechNew Haven, US
Craig Crews(Co-Founder & Scientific Advisor)inMikael Dolsten, M.D., Ph.D.(Co-founder and Executive Chairman of the Board)Craig Crews, Ph.D.(Co-Founder & Scientific Advisor)Dan McHugh(Manager)Tim Shannon(CEO and Board Member)inJeanne Magram(Chief Scientific Officer)in
Co-investorsF-Prime CapitalCanaan PartnersLilly Ventures
Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Jennifer Doudna(Co-founder, Nobel Laureate in Chemistry and Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, UC Berkeley)Rodolphe Barrangou(Co-founder, Associate Professor of Medicine, UCSF)Krishnendu Roy(Co-founder, Professor of Bioengineering, Stanford University)Connor Tsuchida(Scientific Cofounder)in
Co-investorsThird Rock VenturesRA CapitalSozo Ventures
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder)inJack Dent(Founder)inJosh Meier(CEO)Jacques Boitreaud(Founder)Jacques Boutreau(Founder)Joshua Meier Jack Dent(Founder)
Co-investorsAmplify PartnersAvenir Growth CapitalavraBain Capital VenturesBattery VenturesDCVC (Data Collective)+30 more
Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics.
Digital HealthHealthtechMental HealthPhiladelphia, US
Justin Bekelman(Executive Officer, Director)inJonathan Rhodes(Founder)inPaul Dufault(Executive Officer)Roy Beveridge(Director)
BoardKelsey Maguire(Director)Ambar Bhattacharyya(Director)
Co-investorsBlue Venture FundsHealthier CapitalMaverick VenturesOncology VenturesAlpha PartnersSandbox Industries
Fourier Optics builds Fourier AR, an angular and wavelength-selective metasurface optical combiner embedded invisibly inside ophthalmic lenses that reflects RGB light from a µLED projector to the eye for all-day augmented-reality glasses.
Deep TechHardwareSemiconductors
Dr. Omri Barlev(Founder & CEO)Shoam Shwartz(Founder & CTO)inAsaf Carmel(Founder & VP R&D)in
BoardJoe O'keeffe(Chairman)
Co-investorsMaverick Ventures IsraelLam Capitalfresh.fundInnospark VenturesLasagnaNextGen Venture Partners+1 more
Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems.
AI & Machine LearningData & InfrastructureDigital HealthHealthtech
Christopher Lee(Co-Founder & CEO)inJames Lloyd(Co-Founder & CTO)in
Co-investorsGeneral CatalystNextGen Venture PartnersTau VenturesInnospark VenturesLasagnaMyelin VC
.png)
Healthier Capital is a venture capital firm that invests in technology-enabled healthcare companies seeking to reduce costs and improve care delivery.
Digital HealthFintechHealthtech
Amir Dan Rubin(CEO and Founding Managing Partner)in
Co-investorsModi VenturesBlack Opal VenturesDefine VenturesMacquarie CapitalMaverick VenturesNorwest Venture Partners+2 more
Sage Health provides a connected platform powered by AI that adapts to evolving care and technology requirements.
AI & Machine LearningDigital HealthHealthtechLongevityNew York City, US
Matt Lynch(Founder)inEllen Johnston(Founder)inRaj Mehra(Founder)in
Co-investorsAlumni VenturesDistributed VenturesIVP (Institutional Venture Partners)MaveronMerus CapitalP101 Ventures+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.